171 related articles for article (PubMed ID: 25371445)
1. Association of prostate cancer risk variants with gene expression in normal and tumor tissue.
Penney KL; Sinnott JA; Tyekucheva S; Gerke T; Shui IM; Kraft P; Sesso HD; Freedman ML; Loda M; Mucci LA; Stampfer MJ
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):255-60. PubMed ID: 25371445
[TBL] [Abstract][Full Text] [Related]
2. Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis.
Grisanzio C; Werner L; Takeda D; Awoyemi BC; Pomerantz MM; Yamada H; Sooriakumaran P; Robinson BD; Leung R; Schinzel AC; Mills I; Ross-Adams H; Neal DE; Kido M; Yamamoto T; Petrozziello G; Stack EC; Lis R; Kantoff PW; Loda M; Sartor O; Egawa S; Tewari AK; Hahn WC; Freedman ML
Proc Natl Acad Sci U S A; 2012 Jul; 109(28):11252-7. PubMed ID: 22730461
[TBL] [Abstract][Full Text] [Related]
3. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
[TBL] [Abstract][Full Text] [Related]
4. The identification of trans-associations between prostate cancer GWAS SNPs and RNA expression differences in tumor-adjacent stroma.
Chen X; McClelland M; Jia Z; Rahmatpanah FB; Sawyers A; Trent J; Duggan D; Mercola D
Oncotarget; 2015 Jan; 6(3):1865-73. PubMed ID: 25638161
[TBL] [Abstract][Full Text] [Related]
5. Profiling genetic variation along the androgen biosynthesis and metabolism pathways implicates several single nucleotide polymorphisms and their combinations as prostate cancer risk factors.
Mononen N; Seppälä EH; Duggal P; Autio V; Ikonen T; Ellonen P; Saharinen J; Saarela J; Vihinen M; Tammela TL; Kallioniemi O; Bailey-Wilson JE; Schleutker J
Cancer Res; 2006 Jan; 66(2):743-7. PubMed ID: 16424004
[TBL] [Abstract][Full Text] [Related]
6. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer.
Setlur SR; Chen CX; Hossain RR; Ha JS; Van Doren VE; Stenzel B; Steiner E; Oldridge D; Kitabayashi N; Banerjee S; Chen JY; Schäfer G; Horninger W; Lee C; Rubin MA; Klocker H; Demichelis F
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):229-39. PubMed ID: 20056642
[TBL] [Abstract][Full Text] [Related]
8. A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer.
Nam RK; Zhang WW; Loblaw DA; Klotz LH; Trachtenberg J; Jewett MA; Stanimirovic A; Davies TO; Toi A; Venkateswaran V; Sugar L; Siminovitch KA; Narod SA
Prostate Cancer Prostatic Dis; 2008; 11(3):241-6. PubMed ID: 17876339
[TBL] [Abstract][Full Text] [Related]
9. Expression and Genetic Variation in Neuroendocrine Signaling Pathways in Lethal and Nonlethal Prostate Cancer among Men Diagnosed with Localized Disease.
Lu D; Carlsson J; Penney KL; Davidsson S; Andersson SO; Mucci LA; Valdimarsdóttir U; Andrén O; Fang F; Fall K
Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1781-1787. PubMed ID: 28939587
[No Abstract] [Full Text] [Related]
10. The prostate cancer risk locus at 10q11 is associated with DNA repair capacity.
Rinckleb AE; Surowy HM; Luedeke M; Varga D; Schrader M; Hoegel J; Vogel W; Maier C
DNA Repair (Amst); 2012 Aug; 11(8):693-701. PubMed ID: 22677538
[TBL] [Abstract][Full Text] [Related]
11. A functional polymorphism in MSMB gene promoter is associated with prostate cancer risk and serum MSMB expression.
Xu B; Wang J; Tong N; Mi Y; Min Z; Tao J; Li P; Cheng G; Li J; Wang M; Tang J; Song N; Zhang Z; Zhang W; Wu H; Hua L; Feng N
Prostate; 2010 Jul; 70(10):1146-52. PubMed ID: 20333697
[TBL] [Abstract][Full Text] [Related]
12. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
[TBL] [Abstract][Full Text] [Related]
13. Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk: a replication study in an ethnically homogeneous population.
FitzGerald LM; Thomson R; Polanowski A; Patterson B; McKay JD; Stankovich J; Dickinson JL
Prostate; 2008 Sep; 68(13):1373-9. PubMed ID: 18537123
[TBL] [Abstract][Full Text] [Related]
14. Single-nucleotide polymorphism rs13426236 contributes to an increased prostate cancer risk via regulating MLPH splicing variant 4.
Xiao F; Zhang P; Wang Y; Tian Y; James M; Huang CC; Wang L; Wang L
Mol Carcinog; 2020 Jan; 59(1):45-55. PubMed ID: 31659808
[TBL] [Abstract][Full Text] [Related]
15. Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies.
Lindström S; Hunter DJ; Grönberg H; Stattin P; Wiklund F; Xu J; Chanock SJ; Hayes R; Kraft P
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):873-6. PubMed ID: 20200442
[TBL] [Abstract][Full Text] [Related]
16. PSCA gene variants (rs2294008 and rs2978974) confer increased susceptibility of gallbladder carcinoma in females.
Rai R; Sharma KL; Misra S; Kumar A; Mittal B
Gene; 2013 Nov; 530(2):172-7. PubMed ID: 23988503
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS study.
Zheng SL; Liu W; Wiklund F; Dimitrov L; Bälter K; Sun J; Adami HO; Johansson JE; Sun J; Chang B; Loza M; Turner AR; Bleecker ER; Meyers DA; Carpten JD; Duggan D; Isaacs WB; Xu J; Grönberg H
Prostate; 2006 Oct; 66(14):1556-64. PubMed ID: 16921508
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis.
Pomerantz MM; Shrestha Y; Flavin RJ; Regan MM; Penney KL; Mucci LA; Stampfer MJ; Hunter DJ; Chanock SJ; Schafer EJ; Chan JA; Tabernero J; Baselga J; Richardson AL; Loda M; Oh WK; Kantoff PW; Hahn WC; Freedman ML
PLoS Genet; 2010 Nov; 6(11):e1001204. PubMed ID: 21085629
[TBL] [Abstract][Full Text] [Related]
19. Gene Expression Pathways in Prostate Tissue Associated with Vigorous Physical Activity in Prostate Cancer.
Pernar CH; Parmigiani G; Giovannucci EL; Rimm EB; Tyekucheva S; Loda M; Finn SP; Vander Heiden MG; Fiorentino M; Ebot EM; Mucci LA
Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):751-756. PubMed ID: 33500320
[TBL] [Abstract][Full Text] [Related]
20. Differential Gene Expression in Prostate Tissue According to Ejaculation Frequency.
Sinnott JA; Brumberg K; Wilson KM; Ebot EM; Giovannucci EL; Mucci LA; Rider JR
Eur Urol; 2018 Nov; 74(5):545-548. PubMed ID: 29784192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
